{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:38:00Z","timestamp":1793144280659,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cgh.2024.12.011","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T17:17:55Z","timestamp":1736529475000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review"],"prefix":"10.1016","volume":"23","author":[{"given":"Freddy","family":"Caldera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.12.011_bib1","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1053\/j.gastro.2021.04.023","article-title":"AGA technical review on the medical management of moderate to severe luminal and perianal fistulizing crohn's disease","volume":"160","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.12.011_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.12.011_bib3","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for breast cancer: US Preventive Services Task Force recommendation statement","volume":"331","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.12.011_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.12.011_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.12.011_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/apt.17555","article-title":"Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease","volume":"58","author":"Kreijne","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.12.011_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000001263","article-title":"Practice Bulletin No. 157: Cervical cancer screening and prevention","volume":"127","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cgh.2024.12.011_bib8","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000513","article-title":"Risk of cervical Cancer in Inflammatory Bowel Disease: a meta-analysis of population-based studies","volume":"13","author":"Mann","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cgh.2024.03.032","article-title":"AGA Clinical Practice Update on management of inflammatory bowel disease in patients with malignancy: commentary","volume":"22","author":"Axelrad","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.12.011_bib10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ecco-jcc\/jjad045","article-title":"Anal high-risk human papillomavirus infection, squamous intraepithelial lesions, and anal cancer in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"17","author":"Albuquerque","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International Anal Neoplasia Society's consensus guidelines for anal cancer screening","volume":"154","author":"Stier","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2024.12.011_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib14","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s10620-019-05494-w","article-title":"Receipt of preventive care services among US adults with inflammatory bowel disease, 2015\u20132016","volume":"64","author":"Xu","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.12.011_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MIB.0000437737.68841.87","article-title":"Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement","volume":"20","author":"Wasan","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib17","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/ibd\/izab155","article-title":"Health maintenance consensus for adults with inflammatory bowel disease","volume":"27","author":"Syal","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2021.01.026","article-title":"How to implement a successful vaccination program in outpatient gastroenterology practices: a focus on patients with inflammatory bowel disease and chronic liver disease","volume":"164","author":"Bhat","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.12.011_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M23-0041","article-title":"Recommended adult immunization schedule, United States, 2023","volume":"176","author":"Murthy","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2024.12.011_bib20","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.15585\/mmwr.mm7246a3","article-title":"Progress toward measles elimination - worldwide, 2000\u20132022","volume":"72","author":"Minta","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib21","author":"Kroger"},{"key":"10.1016\/j.cgh.2024.12.011_bib22","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib23","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcv.2013.01.015","article-title":"Varicella immunity in vaccinated healthcare workers","volume":"57","author":"Behrman","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cgh.2024.12.011_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10620-018-5321-z","article-title":"Immunosuppression does not affect antibody concentrations to measles, mumps, and rubella in patients with inflammatory bowel disease","volume":"64","author":"Caldera","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.12.011_bib26","series-title":"CDC Yellow Book 2024: Health Information for International Travel","year":"2023"},{"key":"10.1016\/j.cgh.2024.12.011_bib27","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ibd\/izab266","article-title":"Safety of immunizations for the adult patient with inflammatory bowel disease-a systematic review and meta-analysis","volume":"28","author":"Desalermos","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib28","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s10620-019-06016-4","article-title":"Safety of recombinant zoster vaccine in patients with inflammatory bowel disease","volume":"65","author":"Satyam","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.12.011_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ibd\/izac174","article-title":"Postvaccination symptoms after a third dose of mRNA SARS-CoV\u20132 vaccination in patients with inflammatory bowel disease: results from CORALE-IBD","volume":"29","author":"Li","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib30","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ibd\/izab302","article-title":"Impact of SARS-CoV\u20132 vaccination on inflammatory bowel disease activity and development of vaccine-related adverse events: results from PREVENT-COVID","volume":"28","author":"Weaver","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/ecco-jcc\/jjad085","article-title":"Impact of holding immunosuppressive therapy in patients with inflammatory bowel disease Around mRNA COVID-19 vaccine administration on humoral immune response and development of COVID-19 infection","volume":"17","author":"Motwani","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gut.2010.208413","article-title":"Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy","volume":"59","author":"Loras","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.12.011_bib34","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/ibd.22905","article-title":"Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases","volume":"18","author":"Park","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2024.12.011_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib39","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.vaccine.2019.12.036","article-title":"Cross-sectional study of hepatitis B antibody status in healthcare workers immunized as children at an academic medical center in Wisconsin","volume":"38","author":"Ritscher","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2024.12.011_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2024.12.011_bib43","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.15585\/mmwr.mm7348a3","article-title":"Updated recommendation for universal hepatitis B vaccination in adults aged 19\u201359 years \u2014 United States, 2024","volume":"73","author":"Sandul","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib44","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1007\/s10620-024-08527-1","article-title":"High rates of seroprotection to hepatitis B after a hepatitis B challenge dose in previously vaccinated patients with inflammatory bowel disease on immunosuppressive therapy","volume":"69","author":"Ley","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.12.011_bib45","article-title":"High rate of seroprotection with HEPLISAV-B in patients with inflammatory bowel disease","author":"Hedge","year":"2024","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib46","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.14309\/ajg.0000000000002863","article-title":"Utility of a third Heplisav-B dose in patients with inflammatory bowel disease without immunity following two-dose Heplisav-B vaccination","volume":"119","author":"Karime","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib48","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1001\/jama.2019.6587","article-title":"Screening for HIV infection: US Preventive Services Task Force recommendation statement","volume":"321","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.12.011_bib49","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib50","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.12.011_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022\u201323 influenza season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib52","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A\u00a0Double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib53","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MCG.0000000000001635","article-title":"The burden of vaccine-preventable diseases in patients with inflammatory bowel disease","volume":"56","author":"Kr\u00f6ner","year":"2022","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib54","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/ecco-jcc\/jjv152","article-title":"Immunogenicity and safety of influenza vaccine in inflammatory bowel disease patients treated or not with immunomodulators and\/or biologics: a two-year prospective study","volume":"9","author":"Launay","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.crohns.2013.08.008","article-title":"Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease","volume":"8","author":"Hagihara","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib56","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ibd\/izx101","article-title":"Immunogenicity of quadrivalent influenza vaccine for patients with inflammatory bowel disease undergoing immunosuppressive therapy","volume":"24","author":"Shirai","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00535-015-1042-7","article-title":"Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial","volume":"50","author":"Matsumoto","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib58","first-page":"593","article-title":"Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial","volume":"26","author":"Caldera","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ajg.2012.406","article-title":"Increased risk of pneumonia among patients with inflammatory bowel disease","volume":"108","author":"Long","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib60","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2015.284","article-title":"Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977\u20132013","volume":"110","author":"Kants\u00f8","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MCG.0000000000001863","article-title":"Incidence of pneumonia, related hospitalization, and mortality among younger unvaccinated IBD patients in a nationwide cohort","volume":"58","author":"Khan","year":"2024","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cid\/ciz226","article-title":"Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease","volume":"70","author":"van Aalst","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib63","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/ecco-jcc\/jjab017","article-title":"Effectiveness of conjugate and polysaccharide pneumococcal vaccines for prevention of severe pneumococcal disease among inflammatory bowel disease patients","volume":"15","author":"Love","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","article-title":"Respiratory syncytial virus infection in older adults: an under-recognized problem","volume":"32","author":"Branche","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.cgh.2024.12.011_bib65","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.14309\/ajg.0000000000002682","article-title":"Patients With inflammatory bowel disease are at increased risk of hospitalization due to respiratory syncytial virus","volume":"119","author":"Smith","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib66","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.12.011_bib67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.12.011_bib68","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.12.011_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.12.011_bib70","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/apt.17379","article-title":"Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease","volume":"57","author":"Din","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.12.011_bib71","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cgh.2024.12.011_bib72","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/apt.17454","article-title":"Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease","volume":"57","author":"Caldera","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.12.011_bib73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOG.0000000000000710","article-title":"Bone loss in patients with inflammatory bowel disease: cause, detection and treatment","volume":"37","author":"Bravenboer","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.cgh.2024.12.011_bib74","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","article-title":"Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases","volume":"22","author":"Mikocka-Walus","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.12.011_bib75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.crohns.2013.07.002","article-title":"Risk factors for depression in the elderly inflammatory bowel disease population","volume":"8","author":"Long","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.12.011_bib76","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/MCG.0000000000001094","article-title":"Predictors of suicidal ideation among IBD outpatients","volume":"53","author":"Hashash","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356525000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T10:40:10Z","timestamp":1744454410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356525000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1542356525000205"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.12.011","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on Noncolorectal Cancer Screening and Vaccinations in Patients With Inflammatory Bowel Disease: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}